Drug profile · INN
aluminum hydroxide
GAVISCON
aluminum hydroxide (GAVISCON) is a antacid. Route of administration: oral. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — aluminum hydroxide
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
aluminum hydroxide (GAVISCON) is a antacid. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN aluminum hydroxide
Brand GAVISCON
Mechanism Antacid
Route ORAL
Formulation TABLET, CHEWABLE
Mechanism of action
Antacid
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is aluminum hydroxide?
aluminum hydroxide (GAVISCON) is a antacid. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for aluminum hydroxide?
GAVISCON is a marketed brand name for aluminum hydroxide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of aluminum hydroxide?
aluminum hydroxide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.